Group 1 - The core focus of the article is on the corporate governance of Lepu Biopharma-B (02157.HK), highlighting a proposed ten-year restricted share unit plan aimed at incentivizing and retaining employees [1] - The plan is set to be discussed at the second extraordinary general meeting scheduled for December 18, 2025 [1] - The maximum number of shares to be granted under this plan is capped at 5% of the total issued shares as of the adoption date [1]

Core Viewpoint - The company, Meet Xiaomian (02408), announced a proposal for a Restricted Share Unit (RSU) plan aimed at retaining and attracting talent, as well as rewarding qualified individuals for their contributions to the group [1] Group 1: RSU Plan Details - The RSU plan is set to be reviewed and approved by shareholders at the upcoming extraordinary general meeting [1] - Upon the RSU plan's effectiveness, the board plans to conditionally grant a total of 630,000 RSUs to 12 employee participants, who are not directors, the CEO, or major shareholders of the company [1]

Core Viewpoint - The company, Meet Xiaomian (02408), announced a proposal for a restricted share unit plan aimed at retaining and attracting talent, as well as rewarding qualified individuals for their contributions to the group [1] Group 1 - The board of directors decided to recommend the adoption of the restricted share unit plan on January 6, 2026 [1] - The plan will require shareholder review and approval at the upcoming extraordinary general meeting before it can take effect [1] - Upon the plan's effectiveness, the board intends to conditionally grant a total of 630,000 restricted share units to 12 employee participants, who are neither directors, the CEO, nor major shareholders of the company [1]